Butaperazine
 | |
| Clinical data | |
|---|---|
| ATC code | N05AB09 (WHO) |
| Identifiers | |
| |
| CAS Number |
653-03-2  Y |
| PubChem (CID) | 12598 |
| ChemSpider |
12078 Y |
| UNII |
TXP4T9106S Y |
| ChEMBL | CHEMBL1697826 |
| ECHA InfoCard | 100.010.450 |
| Chemical and physical data | |
| Formula | C24H31N3OS |
| Molar mass | 409.59 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| (verify) | |
Butaperazine (Repoise, Tyrylen) is a typical antipsychotic of the phenothiazine class.[1]
See also
References
- ↑ "Evaluation of a new antipsychotic agent. Butaperazine maleate (repoise maleate)". JAMA: the Journal of the American Medical Association. 206 (10): 2307–8. December 1968. doi:10.1001/jama.206.10.2307. PMID 4386884.
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| D1-like |
| ||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D2-like |
| ||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| Receptor (ligands) |
| ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Transporter (inhibitors) |
| ||||||||||||||
| Enzyme (inhibitors) |
| ||||||||||||||
| Others |
| ||||||||||||||
| Classes |
|
|---|---|
| Antidepressants (TCAs and TeCAs) |
|
| Antihistamines |
|
| Antipsychotics |
|
| Anticonvulsants | |
| Others |
|
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.